Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
Year: 2018
Type: article
Abstract: Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols.
Source: Journal of Nuclear Cardiology
Institutions: Wayne State University, John D. Dingell VA Medical Center, University of Maryland, Baltimore, Cook County Health and Hospitals System, Hartford Hospital, Alaska Heart and Vascular Institute, Carolinas Medical Center, University of Alabama at Birmingham, Birmingham VA Medical Center, The University of Texas Health Science Center at Houston, University of Rochester, University of California, Irvine, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W2906507920